Skip to main content
. 2017 Feb 2;17:46. doi: 10.1186/s12887-016-0765-9

Table 3.

Effect of SQ-LNS containing different amounts and sources of zinc provided along with malaria and diarrhea treatment on hemoglobin concentration and iron status indicators among children 9–18 months of age, by study group

LNS-Zn0 LNS-Zn5 LNS-Zn10 LNS-TabZn5 P-value among 4 intervention groupsb IC NIC P-value between cohortsb ICCc DEd
Hemoglobin (g/L)a, e
N (9 and 18 months) 80 73 76 68 297 87
 Hb at 9 months 89 ± 15 87 ± 14 88 ± 16 89 ± 15 0.925 88 ± 15 88 ± 16 0.805 0.02 1.3
 Hb at 18 months 97 ± 17 96 ± 15 98 ± 16 98 ± 15 0.731 97 ± 16 90 ± 15 0.003 0.04 1.5
Plasma ferritin (μg/L)f
N (9 and 18 months) 84 75 79 73 311 93
 Unadjusted pF at 9 months 35.9 (29.6, 43.4) 29.7 (24.9, 35.4) 34.1 (28.5, 40.9) 33.0 (26.5, 41.1) 0.127 33.2 (30.2, 36.5) 27.4 (23.3, 32.3) 0.096 0.00 1.0
 Adjusted pF at 9 months 23.1 (19.4, 27.4) 18.5 (15.7, 21.8) 21.6 (18.2, 25.5) 19.7 (16.3, 23.8) 0.166 20.7 (19.0, 22.6) 17.0 (14.6, 19.8) 0.038 0.00 1.0
 Unadjusted pF at 18 months 44.6 (36.3, 54.7) 47.7 (38.9, 58.5) 34.0 (28.7, 40.2) 42.0 (34.0, 52.1) 0.023 41.7 (37.8, 46.0) 27.0 (22.3, 32.8) <0.0001 0.04 1.5
 Adjusted pF at 18 months 29.5 (24.9, 35.0)ab 30.5 (25.2, 36.8)a 22.1 (18.5, 26.4)b 28.6 (23.3, 35.0)ab 0.016 27.4 (25.0, 30.0) 16.9 (14.3, 19.9) <0.0001 0.06 1.8
Soluble transferrin receptor (mg/L)g
N (9 and 18 months) 84 75 79 73 311 93
 Unadjusted sTfR at 9 months 17.8 (15.8, 20.0) 19.7 (17.7, 22.0) 18.4 (16.5, 20.4) 18.4 (14.7, 18.6) 0.286 18.1 (17.1, 19.1) 16.6 (14.8, 18.7) 0.385 0.03 1.4
 Adjusted sTfR at 9 months 15.7 (14.0, 17.6) 17.4 (15.7, 19.4) 16.2 (14.6, 18.0) 14.4 (12.9, 16.1) 0.162 15.9 (15.1, 16.8) 14.6 (13.0, 16.3) 0.270 0.03 1.4
 Unadjusted sTfR at 18 months 8.8 (8.1, 9.6) 9.1 (8.3, 9.9) 9.0 (8.3, 9.8) 9.2 (8.4, 10.0) 0.860 9.0 (8.6, 9.4) 11.9 (10.9, 13.0) <0.0001 0.01 1.1
 Adjusted sTfR at 18 months 7.8 (7.2, 8.5) 8.0 (7.3, 8.7) 8.0 (7.3, 8.6) 8.2 (7.5, 8.9) 0.828 8.0 (7.7, 8.3) 10.6 (9.7, 11.5) <0.0001 0.00 1.0
Body iron stores (mg/kg)
N (9 and 18 months) 84 75 79 73 311 93
 Unadjusted BIS at 9 months 1.06 (0.23, 1.88) 0.00 (–0.75, 0.75) 0.76 (0.06, 1.47) 1.02 (0.18, 1.86) 0.069 0.72 (0.33, 1.10) 0.34 (–0.37, 1.05) 0.521 0.01 1.1
 Adjusted BIS at 9 months –0.08 (–0.88, 0.72) –1.25 (–1.98,–0.52) –0.44 (–1.13, 0.25) –0.35 (–1.14, 0.44) 0.120 –0.52 (–0.89,–0.14) –0.91 (–1.60,–0.22) 0.401 0.01 1.1
 Unadjusted BIS at 18 months 4.37 (3.64, 5.10) 4.51 (3.69, 5.34) 3.30 (2.57, 4.03) 4.02 (3.19, 4.84) 0.025 4.05 (3.67, 4.43) 1.48 (0.76, 2.19) <0.0001 0.05 1.7
 Adjusted BIS at 18 months 3.31 (2.66, 3.97)ab 3.35 (2.56, 4.14)a 2.21 (1.44, 2.98)b 3.04 (2.25, 3.83)ab 0.019 2.98 (2.61, 3.35) 0.22 (–0.44, 0.88) <0.0001 0.06 1.8
Zinc protoporphyrin (μmol/mol heme)h
N (9 and 18 months) 81 73 79 73 306 92
 Unadjusted ZPP at 9 months 212 (184, 244) 235 (206, 269) 208 (186, 233) 202 (177, 230) 0.703 214 (200, 228) 198 (169, 233) 0.646 0.10 2.2
 Adjusted ZPP at 9 months 193 (167, 223) 212 (185, 242) 188 (169, 210) 180 (158, 204) 0.574 193 (181, 206) 180 (154, 210) 0.625 0.09 2.1
 Unadjusted ZPP at 18 months 144 (129, 161) 151 (137, 168) 151 (132, 159) 145 (132, 156) 0.920 146 (139, 153) 203 (184, 225) <0.0001 0.05 1.7
 Adjusted ZPP at 18 months 132 (118, 148) 137 (124, 151) 132 (122, 144) 133 (121, 145) 0.946 133 (127, 140) 182 (164, 203) <0.0001 0.05 1.7

Hb hemoglobin concentration, pF plasma ferritin, sTfR soluble transferrin receptor, ZPP zinc protoporphyrin

aAdjusted means ± standard deviation, and geometric mean (95% confidence interval); all such values

bValues in a row with superscripts with different letters differ P < 0.05 using Proc MIXED. Values are adjusted for the random effect of the village

cInter-cluster coefficient calculated based on the cluster (village) variance and the residual variance from proc MIXED

dDesign effect calculated based on the standard error of the intervention with or without the random effect of the cluster

eHb values adjusted for AGP, CRP, and at 18 months, adjusted additionally for baseline value and study season

fpF values adjusted for AGP, CRP, and at 18 months, adjusted additionally for baseline value, baseline iron supplementation, RDT, maternal BMI and study season

gsTfR values adjusted for AGP, CRP, age and sex; and at 18 months, adjusted additionally for baseline value, baseline iron supplementation, study season, and minimum meal frequency

hZPP values adjusted for AGP, CRP and sex; and at 18 months, adjusted additionally for baseline value, baseline iron supplementation, maternal BMI, study season, and animal food source